Congenital Cytomegalovirus and Hearing Loss in Children
Title: Congenital Cytomegalovirus and Hearing Loss in Children
WHEN YOU COMPLETE THE REGISTRATION FORM BELOW, YOU WILL HAVE IMMEDIATE ACCESS TO THE RECORDED WEBINAR
Description:
Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects and developmental disabilities. cCMV will cause more disabilities in children than many other well-known infections or syndromes. AND, it is the leading viral cause of hearing loss in children. However, there is still very little awareness about this virus. As hearing professionals, we are frequently some of the first providers interacting with children and families impacted by cCMV. This presentation will discuss a variety of topics surrounding cCMV, including cCMV related hearing loss, different CMV screening approaches, and the current efforts to increase cCMV education and screening in Washington State.
Learning Objectives
After attending this webinar, participants will be able to:
- Describe cCMV and the serious consequences of this pervasive virus
- Describe the role of hearing professionals as first line providers for children and families impacted by cCMV
- List the current efforts to increase education, awareness, and screening in Washington State
Presenter: Mallory Baker
Mallory R. Baker, AuD, CCC-A, is a pediatric audiologist at Seattle Children’s Hospital. Prior to joining Seattle Children’s, she practiced at the Children’s Hospital of Philadelphia and the University of North Carolina Hospitals in Chapel Hill. Her professional interests include pediatric hearing loss diagnosis and intervention, and congenital cytomegalovirus related hearing loss. Dr. Baker is the founder and director of the Washington CMV Project. In 2020, she created the Washington CMV Project to increase education about and awareness of congenital CMV, and to advocate for newborn CMV screening in Washington State. Dr. Baker is the current principal investigator on several studies researching congenital CMV.
This webinar was previously provided live on November 3, 2023.